What is ANI Pharmaceuticals's operating margin?

ANI Pharmaceuticals (ANIP) reported operating margin of 13.4% in Q1 2026.

What is the long-term trend for ANI Pharmaceuticals's operating margin?

Over 4 years (2020 to 2025), ANI Pharmaceuticals's operating margin has grown at a 13.1% compound annual growth rate (CAGR), from -7.7% to 12.6%.

What does operating margin mean?

Operating income as a percentage of revenue (trailing twelve months). Captures profitability from core operations after both cost of revenue and operating expenses, but before interest and taxes.

ANI Pharmaceuticals ANIP Operating margin

Operating margin at other companies

Amneal Pharmaceuticals, Inc.AMRX

14.3%+1.6pp

ViatrisVTRS

1%—

AnaptysBio, Inc.ANAB

17.6%+9.6pp

ALN

Alnylam PharmaceuticalsALNY

17.5%+14.4pp

Aurinia PharmaceuticalsAUPH

41.7%+29.4pp

AmgenAMGN

28.4%+6.6pp

Other financials

Income statement

See full

Revenue$237.5M+20.5%

Gross profit$143.9M+16.0%

Operating income$38.9M+48.5%

Net income$29.5M+88.1%

EPS (diluted)$1.28+85.5%

Balance sheet

See full

Cash & equivalents$311.2M+108%

Total debt$305.3M-3.5%

Total equity$562.3M+34.3%

Total assets$1.4B+10.0%

Cash flow

See full

Operating cash flow$58.4M+66.8%

CapEx$6.1M+146%

Free cash flow$52.3M+60.8%

Valuation

See full

Market cap$1.89B+18.3%

Enterprise value$1.88B+5.8%

P/E20.5×—

P/S2×-0.3×

Profitability

See full

Gross margin60.8%+1.5pp

Net margin10%+8.1pp

FCF margin20.7%+10.8pp

Returns & leverage

See full

Return on equity18.8%+15.6pp

Debt / equity0.5×-0.2×

Current ratio3.1×+0.5×

Where this comes from

Calculated from ANI Pharmaceuticals’s reported figures.

operating income/total revenue=13.4%

Based on trailing twelve months.

The official record: ANI Pharmaceuticals’s 10-Q, filed May 8, 2026, on SEC EDGAR. View the filing →

Ask your AI about ANI Pharmaceuticals's operating margin.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is ANI Pharmaceuticals's operating margin?: ANI Pharmaceuticals (ANIP) reported operating margin of 13.4% in Q1 2026.
What is the long-term trend for ANI Pharmaceuticals's operating margin?: Over 4 years (2020 to 2025), ANI Pharmaceuticals's operating margin has grown at a 13.1% compound annual growth rate (CAGR), from -7.7% to 12.6%.
What does operating margin mean?: Operating income as a percentage of revenue (trailing twelve months). Captures profitability from core operations after both cost of revenue and operating expenses, but before interest and taxes.